Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Results    save search

Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
Published: 2024-03-05 (Crawled : 15:00) - biospace.com/
APVO 3 d | $0.76 6.67% 6.25% 220K twitter stocktwits trandingview |
Health Technology
| | O: 4427.49% H: 0.0% C: -11.13%

business update therapeutics financial results
TransCode Therapeutics Announces Positive Results in Non-human Primates with its Lead Therapeutic Candidate, TTX-MC138
Published: 2023-07-31 (Crawled : 11:00) - globenewswire.com
RNAZ | $0.5195 3.59% 3.46% 270K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: 3986.21% H: 1.43% C: -7.17%

mc138 ttx-mc138 positive therapeutics results
Katapult to Announce Second Quarter 2023 Financial Results on August 9, 2023
Published: 2023-07-26 (Crawled : 20:00) - globenewswire.com
KPLT | $8.675 -0.86% -0.86% 8.9K twitter stocktwits trandingview |
Real Estate and Rental and Leas...
| | O: 2368.75% H: 5.01% C: -3.8%

financial results
Neovasc to Report First Quarter Financial Results on May 12, 2022
Published: 2022-04-29 (Crawled : 13:20) - globenewswire.com
NVCN | $30.03 1.66% -2.02% 0 twitter stocktwits trandingview |
Health Technology
| | O: 2289.74% H: 0.0% C: 0.0%

report results
Avinger to Announce Full-Year 2021 Results on March 22
Published: 2022-03-15 (Crawled : 12:30) - biospace.com/
AVGR | $3.89 6.0% 5.66% 17K twitter stocktwits trandingview |
Health Technology
| | O: 1724.4% H: 0.0% C: 0.0%

results
PolarityTE Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-16 (Crawled : 12:00) - prnewswire.com
PTE | $0.241 -0.82% -6.68% 0 twitter stocktwits trandingview |
Consumer Durables
| | O: 1599.62% H: 4.16% C: -5.48%

results
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
Published: 2023-08-10 (Crawled : 11:00) - globenewswire.com
SYBX | $1.74 -1.7% -1.72% 70K twitter stocktwits trandingview |
Health Technology
| | O: 1406.8% H: 1.37% C: 0.87%

business update financial results
Vistagen Announces Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
Published: 2023-08-07 (Crawled : 14:00) - biospace.com/
VTGN | $4.69 0.43% 0.43% 200K twitter stocktwits trandingview |
Health Technology
| | O: 1090.48% H: 0.0% C: 0.0%

ph94 positive spray trial results
NRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
NRXP 1 d | $3.025 -27.63% -38.18% 760K twitter stocktwits trandingview |
Manufacturing
| | O: 895.97% H: 14.34% C: 11.7%

business year update pharmaceuticals financial results
Novan Reports First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-11 (Crawled : 23:00) - globenewswire.com
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: 895.67% H: 5.22% C: -3.48%

financial results results
Bionomics Announces Positive Topline Results from the Phase 2b ATTUNE Clinical Trial of BNC210 in Patients with Post-Traumatic Stress Disorder (PTSD)
Published: 2023-09-28 (Crawled : 10:00) - globenewswire.com
BNOX | $0.9591 -1.17% 18K twitter stocktwits trandingview |
n/a
| | O: 480.71% H: 12.06% C: -41.08%

bnc210 positive topline trial results
Soleno Therapeutics Announces Positive Statistically Significant Top-line Results from Randomized Withdrawal Period of Study C602 of DCCR for Prader-Willi Syndrome
Published: 2023-09-26 (Crawled : 12:00) - globenewswire.com
SLNO 4 | $37.15 -1.98% -2.02% 260K twitter stocktwits trandingview |
Health Technology
| | O: 374.04% H: 44.29% C: 27.62%

positive therapeutics results study
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results
Published: 2023-06-06 (Crawled : 10:00) - intellipharmaceutics.com
IPCIF | $0.135 -29.49% 16K twitter stocktwits trandingview |
Health Technology
| | O: 350.0% H: 0.0% C: 0.0%

year results
Madrigal Pharmaceuticals To Announce Topline Results from the Phase 3 MAESTRO-NASH Study of Resmetirom on Monday, December 19th
Published: 2022-12-18 (Crawled : 00:00) - globenewswire.com
MDGL | $222.18 -2.7% -2.8% 270K twitter stocktwits trandingview |
Health Technology
| | O: 219.37% H: 0.0% C: 0.0%

pharmaceuticals topline results study
Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx® for Pediatric ADHD Patients in Japan
Published: 2024-02-26 (Crawled : 14:30) - biospace.com/
AKLI | $0.238 11.63% 10.42% 200K twitter stocktwits trandingview |
| | O: 193.1% H: 13.69% C: -30.36%

endeavorrx japan positive adhd trial results
BeyondSpring Announces Positive Topline Results from its DUBLIN-3 Registrational Trial of Plinabulin in Combination with Docetaxel for the Treatment of 2nd/3rd Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Wild Type
Published: 2021-08-04 (Crawled : 12:00) - biospace.com/
BYSI | $1.81 -2.16% -2.21% 56K twitter stocktwits trandingview |
Health Technology
| | O: 191.8% H: 6.76% C: -5.41%

treatment lung cancer positive results cancer topline trial plinabulin
Avricore Health Corporate Updates on Audited Results for 2022
Published: 2023-05-02 (Crawled : 12:00) - globenewswire.com
AVCRF | $0.069 207.83% 18K twitter stocktwits trandingview |
Health Technology
| | O: 182.54% H: 0.0% C: 0.0%

health results
Pyxus International, Inc. to Announce Second Quarter Fiscal Year 2023 Financial Results on November 10, 2022
Published: 2022-11-03 (Crawled : 22:00) - prnewswire.com
PYYX | $3.4 10.8% 700 twitter stocktwits trandingview |
Retail Trade
| | O: 172.73% H: 130.0% C: 66.67%

year financial results
Creative Medical Technology Announces Positive Top-Line Results for Type 2 Diabetes Study
Published: 2023-04-12 (Crawled : 18:00) - biospace.com/
CELZ | $4.91 -1.7% -1.73% 14K twitter stocktwits trandingview |
| | O: 160.33% H: 5.56% C: -30.56%

positive medical technology diabetes results study
Soligenix Announces Positive Clinical Results from Compatibility Study of HyBryte™ in the Treatment of Cutaneous T-Cell Lymphoma
Published: 2023-05-04 (Crawled : 12:00) - biospace.com/
SNGX | $0.42 -17.65% -21.43% 6.3M twitter stocktwits trandingview |
Health Technology
| | O: 150.7% H: 17.98% C: -35.96%

t-cell positive treatment results study
Gainers vs Losers
64% 36%

Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M twitter stocktwits trandingview |
Finance

ZCMD | $2.86 108.76% 52.1% 2.3M twitter stocktwits trandingview |
Commercial Services

INVO | $1.555 104.6% 51.13% 5M twitter stocktwits trandingview |
Health Technology

ISPC | $0.437 105.16% 49.53% 37M twitter stocktwits trandingview |
Professional, Scientific, and T...

WLGS | News | $0.92 84.0% 45.65% 1.6M twitter stocktwits trandingview |

OST | $0.499 21.38% 45.26% 1.9M twitter stocktwits trandingview |

XPON | News | $3.1 60.62% 37.74% 17M twitter stocktwits trandingview |

TIRX | $0.7 44.39% 30.74% 58M twitter stocktwits trandingview |

BNTC | News | $6.92 44.17% 30.64% 3.5M twitter stocktwits trandingview |
Health Technology

GGE | $0.035 19.86% 29.3% 64M twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.